Study guide

9.4 Subgaleal Hemorrhage, Neonatal Sepsis & Meningitis, and Perinatal Substance Exposure (NOWS)

Neonatal Pediatric Transport C-NPT

Track your progress as you read

Finished sections get a check mark.

1 Introduction: The C-NPT Exam

About the C-NPT Exam: 2026 Format, Eligibility & Content Outline

2 Chapter 1: Transport Systems, Regulatory Framework & Legal Issues

1.1 Transport System Architecture, Accreditation (CAMTS) & Dispatch Triage 1.2 Regulatory & Legal Mandates: EMTALA, HIPAA, Consent & Documentation 1.3 Medical Direction, Scope of Practice & Ethical Considerations

3 Chapter 2: Safety, Communication, Crew Resource Management & Transport Environment

2.1 Crew Resource Management (CRM), Situational Awareness & Sterile Cockpit 2.2 Aircraft & Ground Ambulance Operations, Landing Zones & Vehicle Dynamics 2.3 Environmental Hazards, Weather Minimums & In-Flight Emergency Procedures 2.4 Communication in Transport: Peer Handoffs, Age-Appropriate Care, Families & Crew Stressors 2.5 Infection Control, PPE, Scene Safety & Disaster/Evacuation Planning

4 Chapter 3: Flight Physiology & Environmental Stressors

3.1 Physical Gas Laws & Transport Implications (Boyle, Dalton, Charles, Henry, Graham) 3.2 Altitude Hypoxia, Barometric Pressure Changes & Dysbarism 3.3 Acceleration Forces (G-forces), Vibration & Acoustic Stress in Transit 3.4 Thermoregulation Physics & Neutral Thermal Environment in Transit

5 Chapter 4: Invasive Procedures & Transport Monitoring

4.1 Advanced Airway Management & Endotracheal Intubation in Transit 4.2 Pleural Decompression (Needle Thoracostomy & Chest Tube Management) 4.3 Vascular Access: Umbilical Lines (UAC/UVC), Intraosseous (IO) & Arterial Lines

6 Chapter 5: Transport Equipment, Respiratory Physiology & Mechanical Ventilation

5.1 Transport Incubators (Isolettes), Thermal Control & Electrical/Gas Power Systems 5.2 Portable Ventilators & Modes (PC, VC, PRVC, High Frequency) 5.3 Gas Cylinder Duration Calculations, Oxygen Delivery & Inhaled Nitric Oxide (iNO) 5.4 Respiratory Physiology: Acid-Base Balance, Oxygenation, Lung Mechanics & Troubleshooting

7 Chapter 6: Transport Pharmacology, Resuscitation, Fluids & Electrolytes

6.1 Vasoactive Infusions & Inotropes (Epinephrine, Dopamine, Dobutamine, Milrinone) 6.2 Sedation, Analgesia & Neuromuscular Blockade in Transport 6.3 Prostaglandin E1 (Alprostadil) & Surfactant Replacement Therapy 6.4 Resuscitation Protocols (NRP, PALS) & Shock Fluid Resuscitation 6.5 Antimicrobial Pharmacology in Neonatal & Pediatric Transport 6.6 Post-Resuscitation Care, Defibrillation & Cardioversion in Transit, ECMO Indications & the Transport-vs-Stay Decision 6.7 Fluid & Electrolyte Therapy Across the Ages: Maintenance, Dehydration, Fluid Overload & Electrolyte Emergencies

8 Chapter 7: Neonatal Respiratory Pathologies & Management

7.1 Respiratory Distress Syndrome (RDS) & Surfactant Deficiency 7.2 Meconium Aspiration Syndrome (MAS) & Persistent Pulmonary Hypertension (PPHN) 7.3 Transient Tachypnea (TTN), Neonatal Pneumothorax & Congenital Diaphragmatic Hernia (CDH) 7.4 Neonatal Upper Airway Anomalies, Aspiration, Pneumonia, Chronic Lung Disease & Respiratory Failure

9 Chapter 8: Neonatal Cardiovascular Critical Care

8.1 Ductal-Dependent Cyanotic Congenital Heart Defects (TGA, TOF, Tricuspid Atresia) 8.2 Ductal-Dependent Systemic Blood Flow Lesions (HLHS, Coarctation, Interrupted Arch) 8.3 Neonatal Arrhythmias, Cardiogenic Shock & Post-Resuscitation Care 8.4 Acyanotic Congenital Heart Lesions, Patent Ductus Arteriosus, Obstructed TAPVR & Neonatal Heart Failure

10 Chapter 9: Neonatal Neurological & Metabolic Crises

9.1 Hypoxic-Ischemic Encephalopathy (HIE) & Passive/Active Therapeutic Hypothermia 9.2 Neonatal Seizures & Intraventricular Hemorrhage (IVH) 9.3 Neonatal Hypoglycemia, Electrolyte Derangements & Hyperbilirubinemia 9.4 Subgaleal Hemorrhage, Neonatal Sepsis & Meningitis, and Perinatal Substance Exposure (NOWS)

11 Chapter 10: Neonatal Surgical Emergencies, Neural Tube Defects & ELBW Care

10.1 Abdominal Wall Defects (Gastroschisis vs. Omphalocele) & TEF/Esophageal Atresia 10.2 Necrotizing Enterocolitis (NEC), Malrotation with Volvulus & Intestinal Obstruction 10.3 Care of the Extremely Low Birth Weight (ELBW) Infant (<1000g) in Transit 10.4 Neural Tube Defects: Myelomeningocele, Encephalocele & Transport of the Newborn With an Open Spinal Defect

12 Chapter 11: Pediatric Respiratory Emergencies

11.1 Acute Upper Airway Obstruction (Croup, Epiglottitis, Bacterial Tracheitis, Foreign Body) 11.2 Lower Airway Crises: Status Asthmaticus & Severe Bronchiolitis 11.3 Pediatric Acute Respiratory Distress Syndrome (PARDS) & Severe Pneumonia

13 Chapter 12: Pediatric Shock & Cardiovascular Crises

12.1 Pathophysiology & Transport Management of Pediatric Septic Shock 12.2 Hypovolemic, Cardiogenic & Anaphylactic Shock in Children 12.3 Pediatric Cardiac Emergencies: SVT, Ventricular Arrhythmias & Myocarditis 12.4 Pediatric Cardiovascular Crises: Palliated Congenital Heart Disease, Pulmonary Hypertensive Crisis, Pericarditis & Tamponade, Hypertensive Emergency & Anterior Mediastinal Mass

14 Chapter 13: Pediatric Neurological Emergencies & Trauma

13.1 Status Epilepticus, Altered Mental Status & Meningitis/Encephalitis 13.2 Pediatric Traumatic Brain Injury (TBI) & Increased Intracranial Pressure (ICP) 13.3 Blunt/Penetrating Trauma, Spinal Motion Restriction & Thermal Burns 13.4 Non-Accidental Trauma, Smoke Inhalation (Carbon Monoxide & Cyanide) & Heat Illness

15 Chapter 14: Pediatric Toxicological, Environmental & Endocrine Emergencies

14.1 Common Pediatric Toxic Ingestions, Poisonings & Antidotes 14.2 Diabetic Ketoacidosis (DKA) & Environmental Emergencies (Submersion, Hypothermia) 14.3 Button Battery & Foreign-Body Ingestions, Bites & Envenomations, and Hazardous-Material Exposures

16 Chapter 15: Pediatric Metabolic & Hematologic Emergencies

15.1 Anemia, Sickle Cell Disease, Coagulopathies & Blood Product Administration 15.2 Oncologic Emergencies, Acute Kidney Injury & Pediatric Electrolyte Crises

9.4 Subgaleal Hemorrhage, Neonatal Sepsis & Meningitis, and Perinatal Substance Exposure (NOWS)

Key Takeaways Explain This Topic AI

Subgaleal hemorrhage, most often after vacuum-assisted delivery, forms a fluctuant swelling that crosses suture lines and can hold a large share of a newborn's blood volume, causing hypovolemic shock and coagulopathy.

Cephalohematoma is subperiosteal and does not cross sutures, and caput succedaneum is scalp edema present at birth; neither usually causes shock, whereas subgaleal hemorrhage can.

Neonatal sepsis and meningitis present with nonspecific signs such as temperature instability, apnea, poor feeding, lethargy, and seizures; a bulging fontanelle and stiff neck are late or absent.

Neonatal opioid withdrawal syndrome typically begins within about 24–72 hours for short-acting opioids but may appear up to about 5 days or later after methadone or buprenorphine; naloxone is not given to newborns of opioid-dependent mothers because it can precipitate seizures.

The Eat, Sleep, Console approach prioritizes non-pharmacologic care, and a 2023 randomized trial found it shortened the time to medical readiness for discharge compared with Finnegan-based care.

Last updated: September 2026

  • Subgaleal Hemorrhage, Neonatal Sepsis & Meningitis, and Perinatal Substance Exposure
  • Subgaleal Hemorrhage: The Scalp Bleed That Causes Shock

The subgaleal space lies between the galea aponeurotica and the periosteum of the skull. It extends from the orbital ridges to the nape of the neck and ears and is not limited by sutures. Traction during vacuum-assisted delivery (the most common association), forceps, or difficult births can tear emissary veins and bleed into this large potential space.

Scalp swellings compared

  • Feature Caput succedaneum Cephalohematoma Subgaleal hemorrhage
  • Location Scalp edema above the periosteum Blood under the periosteum Blood between galea and periosteum
  • Crosses sutures? Yes No (bounded by sutures) Yes
  • Timing Present at birth, resolves in days Appears over hours, resolves over weeks Expands over hours to days

Feel Soft, pitting edema Firm, well-demarcated Fluctuant, boggy; may shift with position; can extend to neck, ears, and eyelids

  • Risk Minimal Hyperbilirubinemia, rarely infection Hypovolemic shock, coagulopathy, death
  • Recognition and management

Serial head circumference measurements and marking the swelling's edges show progression. A commonly cited estimate is that each 1 cm increase in head circumference represents roughly 40 mL of blood in a term infant.

Watch for pallor, tachycardia, falling hematocrit, poor perfusion, and hypotension. Shock can develop hours after birth.

Coagulopathy is common, both as a cause (for example, vitamin K deficiency) and as a consequence (consumption).

Transport care: Establish reliable vascular access (UVC), give volume and packed red blood cells for hemorrhagic shock, correct coagulopathy with fresh frozen plasma , platelets, and cryoprecipitate as indicated, confirm vitamin K was given, and monitor for hyperbilirubinemia. Avoid pressure wraps, which can push blood elsewhere without stopping the bleeding.

  • Neonatal Sepsis and Meningitis
  • Timing and organisms

Early-onset sepsis (EOS): Within the first days of life (commonly defined as the first 72 hours). Usually acquired from the mother. Group B streptococcus and E. coli predominate, with Listeria as a less common but important cause.

Late-onset sepsis (LOS): After 72 hours, often in NICU patients with central lines. Coagulase-negative staphylococci, S. aureus , gram-negative rods, and Candida in ELBW infants.

Presentation

Neonatal sepsis and meningitis are nonspecific :

  • Temperature instability (hypothermia is common in preterm infants)
  • Apnea and bradycardia, respiratory distress
  • Poor feeding, vomiting, abdominal distension
  • Lethargy, irritability, poor tone, seizures
  • Hypoglycemia or hyperglycemia, metabolic acidosis
  • Poor perfusion progressing to shock (cold shock is common)

A bulging fontanelle and neck stiffness are late or absent in neonatal meningitis. Up to a quarter of septic neonates may have meningitis, and blood cultures can be negative in neonatal meningitis. That is why a lumbar puncture is planned when the infant is stable enough, but it is never allowed to delay antibiotics (Section 13.1).

Treatment

Draw cultures, then give antibiotics without delay (Section 6.5):

EOS: ampicillin + gentamicin

Suspected meningitis: meningitic-dose ampicillin plus an extended-spectrum cephalosporin ( ceftazidime or cefepime in the U.S.)

Neonatal HSV: Consider when there are vesicles, seizures (especially focal), elevated liver enzymes, CSF pleocytosis with negative Gram stain, or maternal genital lesions. Neonatal HSV presents as skin-eye-mouth, CNS, or disseminated disease, typically in the first 1–4 weeks. Start acyclovir 20 mg/kg IV every 8 hours without waiting for results.

Treat shock (Sections 8.3 and 12.1), hypoglycemia (Section 9.3), and seizures (Section 9.2).

Infants with GBS or other bacterial meningitis are at risk of hearing loss, hydrocephalus, and cerebral abscess. The receiving team will need the exact culture times.

Perinatal Substance Exposure and Neonatal Opioid Withdrawal Syndrome (NOWS)

"Perinatal substance disorder" in the NCC outline covers exposure to opioids, other drugs, and alcohol in utero.

Neonatal opioid withdrawal syndrome

Timing depends on the drug:

  • Short-acting opioids (heroin, many prescription opioids): signs usually appear within about 24–72 hours
  • Methadone and buprenorphine: signs may appear from about 72 hours to 5 days or later

Signs: High-pitched cry, irritability, tremors, hypertonia, poor feeding and uncoordinated suck, vomiting, loose stools, sneezing, yawning, nasal stuffiness, sweating, poor sleep, tachypnea, and fever. Seizures are uncommon but possible.

Assessment and treatment:

The traditional Finnegan scoring system has been widely replaced or supplemented by the Eat, Sleep, Console (ESC) approach. ESC asks whether the infant can feed, sleep, and be consoled. It emphasizes rooming-in, skin-to-skin contact, swaddling, a low-stimulation environment, and parental involvement.

In a multicenter randomized trial published in 2023, ESC shortened the time until infants were medically ready for discharge compared with Finnegan-based care.

Medication (usually morphine or methadone) is used when non-pharmacologic care is not enough.

The naloxone rule

Do not give naloxone to a newborn whose mother is known or suspected to be opioid dependent. It can precipitate acute withdrawal, including seizures. NRP does not recommend naloxone during neonatal resuscitation. Support ventilation instead.

Other exposures

Cocaine and methamphetamine: Placental abruption, preterm birth, growth restriction, and vasoconstriction-related complications, rather than a classic withdrawal syndrome

SSRIs: Neonatal adaptation syndrome (jitteriness, tachypnea, feeding problems) and a small increased risk of persistent pulmonary hypertension

Benzodiazepines, barbiturates, and alcohol: Withdrawal that may be delayed. Heavy prenatal alcohol exposure causes fetal alcohol spectrum disorder.

Maternal magnesium sulfate: Neonatal hypotonia, respiratory depression, and potentiation of aminoglycoside and neuromuscular blocking effects (Section 6.5)

Why transports involve these infants: NOWS alone is rarely a transport emergency, but exposed infants may need transfer for prematurity, respiratory depression, seizures, or co-existing conditions. Transport teams must also communicate sensitively and without judgment with the family (Section 2.4).